冻胚移植:有排卵 vs 无排卵内膜准备的系统评价与荟萃分析
有排卵方案显著降低妊娠丢失风险(RR 0.75),临床妊娠率相当;总体活产率无显著差异,但排除高偏倚风险及一个离群试验后活产率显著更高(RR 1.15)。
要点
- 有排卵内膜准备可显著降低冻胚移植后妊娠丢失风险(RR 0.75,95%CI 0.65-0.86)。
- 总体活产率无显著差异,但排除高偏倚风险及离群试验后活产率显著更高。
- 有排卵方案对妊娠期高血压疾病呈保护趋势,巨大儿发生率无显著差异。
核心结论
- 有排卵的内膜准备较人工周期显著降低冻胚移植后的妊娠丢失风险。
- 现有证据提示当周期取消率较低时活产率更高,临床应优先选择有排卵方案并尽量降低周期取消率。
研究设计与样本
- 系统评价与荟萃分析,检索PubMed、Scopus、Web of Science及主要临床试验注册库至2026年2月22日。
- 采用随机效应模型合并风险比(RR)及95%CI,并用GRADE评估证据 certainty。
主要发现
- 有排卵方案显著降低妊娠丢失风险(RR 0.75,95%CI 0.65-0.86;高 certainty)。
- 临床妊娠率两组相当(RR 1.02,95%CI 0.98-1.06;高 certainty)。
- 总体活产率无显著差异(RR 1.07,95%CI 0.95-1.22;中等 certainty)。
- 排除高偏倚风险研究及一个周期取消率组间差异大的离群试验后,有排卵方案活产率显著更高(RR 1.15,95%CI 1.01-1.31)。
- 有排卵方案对妊娠期高血压疾病呈保护趋势(RR 0.77,95%CI 0.55-1.07;中等 certainty),巨大儿发生率无显著差异(RR 0.98,95%CI 0.73-1.30)。
临床怎么用
- 冻胚移植内膜准备应优先选择有排卵方案(自然周期、改良自然周期或刺激周期)。
- 临床管理中应尽量降低周期取消率,以最大化活产率并减少妊娠丢失。
局限性
- 部分结局证据 certainty 为低或极低。
- 总体活产率结果受高偏倚风险研究及一个离群试验影响,排除后结论改变。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To compare the effectiveness and safety of endometrial-preparation methods with ovulation (maintaining a corpus luteum) vs those without ovulation (artificial/programmed cycles) for frozen-embryo transfer. METHODS: We searched PubMed, Scopus, Web of Science and major clinical trial registries from inception to 22 February 2026 for randomized controlled trials (RCTs) comparing endometrial preparation with ovulation (natural, modified natural or stimulated cycles) against endometrial preparation without ovulation (artificial cycles) for frozen-embryo transfer. The primary outcomes were live-birth rate and presence of hypertensive disorders of pregnancy (HDP). Secondary outcomes included clinical-pregnancy rate, cycle cancelation rate, pregnancy loss and neonatal outcomes (preterm birth and birth weight). Risk of bias was assessed using the Cochrane Risk-of-Bias version 2 tool and trustworthiness was evaluated using the INveStigating ProblEmatic Clinical Trials in Systematic Reviews tool. Data were pooled using random-effects meta-analysis to estimate the risk ratio (RR) with 95% CI. A sensitivity analysis was performed excluding studies categorized as having a high risk of bias and those with serious concerns regarding trustworthiness. Certainty of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation approach. RESULTS: We included 17 RCTs involving a total of 10 611 participants. We identified high-certainty evidence that endometrial preparation with ovulation significantly reduced the risk of pregnancy loss (RR, 0.75 (95% CI, 0.65-0.86)) and resulted in equivalent clinical-pregnancy rates (RR, 1.02 (95% CI, 0.98-1.06)) compared with endometrial preparation without ovulation. Moderate-certainty evidence showed comparable live-birth rates overall (RR, 1.07 (95% CI, 0.95-1.22)). However, exclusion of studies at high risk of bias and one outlier trial with a high difference in cycle-cancelation rate between groups revealed significantly higher live-birth rates for endometrial preparation with vs without ovulation (RR, 1.15 (95% CI, 1.01-1.31)). Moderate-certainty evidence also indicated a protective trend against HDP with ovulation (RR, 0.77 (95% CI, 0.55-1.07)), and no significant difference in the rate of macrosomia between groups (RR, 0.98 (95% CI, 0.73-1.30)). Evidence regarding other outcomes was of low or very low certainty. CONCLUSIONS: Endometrial preparation with ovulation offers an advantage over artificial cycles by significantly reducing the risk of pregnancy loss following frozen-embryo transfer. The available evidence also suggests that there are higher live-birth rates when cycle cancelation is minimized. Clinicians should prioritize endometrial preparation with ovulation, aiming for a low cycle-cancelation rate, in order to reduce the rate of pregnancy loss and maximize the rate of live birth in women undergoing frozen-embryo transfer. © 2026 International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Martins WP, Nastri CO. Endometrial preparation with vs without ovulation for frozen-embryo transfer: systematic review and meta-analysis of randomized controlled trials. Ultrasound Obstet Gynecol. 2026. PMID: 42640814. doi:10.1002/uog.70299
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。